A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer.

A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys. 2012 Dec 01; 84(5):1166-71.

View in: PubMed

subject areas

Adenocarcinoma
Aged
Aged, 80 and over
Cause of Death
Deoxycytidine
Disease Progression
Female
Gastrointestinal Tract
Humans
Male
Maximum Tolerated Dose
Middle Aged
Neutropenia
Organs at Risk
Pancreatic Neoplasms
Radiation-Sensitizing Agents
Radiotherapy, Intensity-Modulated
Thrombocytopenia
Time Factors

authors with profiles

Ross Abrams